Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
151.94%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: S$11.00 Billion

As of December 2025 Arrowhead Pharmaceuticals has a market cap of S$11.00 Billion. This makes Arrowhead Pharmaceuticals the world's 2176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025S$11.00 B243.26%
2024S$3.20 B-26.14%
2023S$4.34 B-29.84%
2022S$6.18 B-33.95%
2021S$9.36 B-10.18%
2020S$10.43 B20.63%
2019S$8.64 B450.37%
2018S$1.57 B326.56%
2017S$0.36 B121.34%
2016S$0.16 B-67.92%
2015S$0.51 B-2.78%
2014S$0.53 B-0.48%
2013S$0.53 B1209.58%
2012S$40.94 M-28.32%
2011S$57.11 M-31.01%
2010S$82.78 M77.2%
2009S$46.71 M-17.3%
2008S$56.48 M-73.18%
2007S$0.21 B-8.41%
2006S$0.22 B-3.24%
2005S$0.23 B138.85%
2004S$99.48 M55334.65%
2003S$0.17 M226.77%
2002S$0.05 M-62.51%
2001S$0.14 M-73.62%
2000S$0.55 M32.95%
1999S$0.41 M-3.97%
1998S$0.43 M61.52%
1997S$0.26 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Arrowhead Pharmaceuticals was reported to be:

S$10.81 Billion
by Nasdaq info icon info icon
S$11.00 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
S$78.43 B 612.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.85 B-64.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$4.71 B-57.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S$0.18 B-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$630.46 B 5,627.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$14.02 B 27.41%๐Ÿ‡บ๐Ÿ‡ธ USA